# DAPAGLIFLOZIN

NDC: 71921-421
Generic name: Dapagliflozin
Labeler / Manufacturer: Florida Pharmaceutical Products, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20260406

FDA application: ANDA211156

## Active ingredients

- DAPAGLIFLOZIN: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71921-421"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71921-421
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=20a83ea2-6ad8-4bbb-b516-73c0a9e37399